IP Library Granted Patent US 8,865,431
Granted Patent B2
US 8,865,431 · App. 13/280,837 · Granted Oct 21, 2014

Antigen binding domains

Inventors: Helen Dooley (Baltimore, MD); Andrew Porter (Aberdeen, GB); Martin Flajnik (Baltimore, MD)
Assignees: University of Maryland; Aberdeen University
C07K16/005C07K2317/569C07K2317/20C07K2317/56C07K16/40C07K2317/565
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,865,431
App. No.
13/280,837
Granted
Oct 21, 2014
Kind
B2
Abstract

A process for the production of an antigen specific antigen binding domain using a transformed host containing an expressible DNA sequence encoding the antigen specific antigen binding domain, wherein the antigen specific antigen binding domain is derived from a variable region of the immunoglobulin isotype NAR found in fish.

Claims (30)

1. A process for the production of an antigen specific antigen binding domain comprising the steps of:

(a) immunizing a member of the Elasmobranchii subclass with a specific antigen such that the binding domain is somatically matured;

(b) isolating lymphocytes from the immunizing species;

(c) isolating RNA from the lymphocytes;

(d) amplifying DNA sequences encoding the antigen specific antigen binding domain by PCR;

(e) cloning the amplified DNA into a display vector;

(f) transforming a host to produce a library;

(g) selecting the desired clones from the library;

(h) isolating and purifying the antigen specific antigen binding domain from these clones;

(i) cloning the DNA sequences encoding the antigen specific antigen binding domain into an expression vector;

(j) transforming a host with the expression vector;

(k) culturing the host; and

(l) isolating the antigen specific antigen binding domain so that the antigen specific antigen binding domain is produced.

2. A process according to claim 1 wherein the member is a shark or dog fish.

3. A process according to claim 1 wherein before step (d) the cDNA of the antigen specific antigen binding domain is generated.

4. A process according to claim 1 wherein the restriction enzymes are used to digest the amplified DNA sequences encoding the antigen specific antigen binding domain.

5. A process according to claim 4 wherein the restriction enzymes are NcoI and NotI.

6. A process according to claim 1 wherein the display vector is any phagemid vector.

7. A process according to claim 1 wherein the expression vector is a soluble expression vector.

8. A process for the production of an antigen specific antigen binding domain comprising:

(a) transforming a host with an expressible DNA sequence encoding an antigen specific antigen binding domain, wherein the antigen specific antigen binding domain is derived from a variable region of the immunoglobulin isotype Novel Antigen Receptor (NAR) from a member of the Elasmobranchii subclass immunized with a specific antigen;

(b) culturing the host so that the antigen specific antigen binding domain is expressed; and

(c) isolating the antigen specific antigen binding domain, thereby producing an antigen specific antigen binding domain.

9. The process of claim 8 wherein the member is a shark or dog fish.

10. The process of claim 8 wherein the transformed host is a prokaryote or a lower eukaryote.

11. The process of claim 10 wherein the prokaryote host is Escherichia coli.

12. The process of claim 8 wherein the expressible DNA sequence is in the form of a phagemid vector.

13. The process of claim 8 wherein the member is a nurse shark.

14. The process of claim 8 wherein the antigen specific antigen binding domain is specific for the antigen.

15. The process of claim 8 wherein the antigen specific antigen binding domain is monoclonal.

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 19, 2015
From: UNIVERSITY OF MARYLAND BALTIMORE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 037082/0053 →
Priority Claims (2)
GB 0119553.6 · Aug 10, 2001 · national
GB 0210508.8 · May 8, 2002 · national
Continuity (2)
Continuation 10486608
Related Publication 20120064074A1 · Mar 15, 2012